You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table PDU-1. Prevalence of problem drug use at national level: summary table, 2001-2005, rate per 1000 aged 15-64 [see all tables in this series...]

Part (ii) Injecting drug use

Country		Year	Rate /1000 ages 15-64	Interval for rate /1000	Number of users	Target group, data sources and estimation methods	Reference
Bulgaria		n.a.					1
Czech Republic	*	2005	4.1	[3.4-4.6]	[26800-33500]	IDUs. Low-threshold services and national HCV study among IDUs. Treatment multiplier.	5
Denmark		n.a.
Germany		2005	1.7	[1.4-2.0]	[78000-110500]	Heroin users registered by the police. Mortality multiplier.	18
Estonia	* #	2004	15.1	[8.9-37.1]	13801	IDUs. Estonian Police Database. Health Insurance Fund. State HIV Reference Laboratory. Capture-recapture.	1
Greece	*	2005	1.3	[1.1-1.5]	[8187-10883]	Last month injecting drug users. Treatment data. Capture-recapture.	4
Cyprus	*	2005	0.6	[0.5-0.9]	[258-444]	Current injectors. Treatment data. Truncated Poisson.	2
Hungary		2005	0.6	[0.3-0.8]	[2069-5813]	IDUs. Treatment and police data. Capture-recapture.	2
The Netherlands		2001	0.3	[0.2-0.4]	3115	Problem drug users currently injecting. Treatment Multiplier.	24
Poland		n.a.					7
Slovakia	*	2005	4.7	[3.4-8.2]	[13300-31600]	IDUs. Low-threshold facilities.	1, 3, 4
Finland	* #	2002	4.5	[4.3-5.7]	[12200-19700]	Current injectors of opiates or stimulants. Multiple sources. Combination of multiplier and capture-recapture.	1
Sweden		n.a.					12, 14
United Kingdom	*	2005	4.2	[4.0-4.6]	[158881-178614]	IDUs. The UK estimate is based on the England estimate for 2004/05.	18
Norway		2005	3.3	[2.7-3.8]	[8374-11724]	Overdose deaths, death rates from studies. Mortality multiplier.	4

Notes:

n.a. = not available

* - Interval is a 95% confidence interval

# - Finland: the original age range of study was 15-55, rate was adapted to 15-64. Estonia: Original age range of study was 15-44, rates have been adjusted to 15-64.

For further details on methods and data sources/comments see tables Table PDU-3 and Table PDU-4.

See also 'General notes for interpreting data' on the Explanatory notes and help page.

Sources:

For bibliographic references see Table PDU-0.